Results for tag: "Psoriasis Vulgaris Drug"

The Psoriasis Vulgaris Drug market is a subset of the larger Psoriasis Drugs market, which includes treatments for the chronic skin condition. Psoriasis Vulgaris Drugs are used to treat the most common form of psoriasis, which is characterized by red, scaly patches on the skin. These drugs are typically administered topically, orally, or through injections. Common treatments include topical corticosteroids, vitamin D analogues, retinoids, and immunomodulators. The Psoriasis Vulgaris Drug market is highly competitive, with many companies offering treatments for the condition. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. Other companies in the market include Eli Lilly, Merck, Pfizer, and Sun Pharmaceuticals. Show Less Read more